Parse Biosciences announced the expansion of its Evercode BCR product line to enable applications in mice. The Evercode BCR platform was designed to streamline workflows for antibody research, allowing scientists to identify individual antibody-producing cells and their clonally related groups that generate specific antibodies of interest. The company says the new kits enable researchers to profile the mouse BCR repertoire alongside whole transcriptome data for millions of cells in a single experiment.
